Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Current Opinion in Molecular Therapeutics|January 24, 2002
Technology evaluation: T-cell activator, XenovaK L KnutsonSeminars in Oncology|January 5, 2002
Cancer vaccines targeting the HER2/neu oncogenic proteinM L Disis, K SchiffmanCritical Reviews in Immunology|January 7, 1998
HER-2/neu oncogenic protein: issues in vaccine developmentM L Disis, M A CheeverArchivum Immunologiae Et Therapiae Experimentalis|May 12, 2000
Tumor vaccines for the management of prostate cancerD G McNeel, M L DisisCurrent Opinion in Immunology|October 1, 1996
Oncogenic proteins as tumor antigensM L Disis, M A CheeverAdvances in Cancer Research|January 1, 1997
HER-2/neu protein: a target for antigen-specific immunotherapy of human cancerM L Disis, M A CheeverEndocrinology|September 1, 1994
Identification and subcellular characterization of protein kinase-C isoforms in insulinoma beta-cells and whole isletsK L Knutson, M HoenigJournal of Cellular Biochemistry|January 1, 1996
Regulation of distinct pools of protein kinase C delta in beta cellsK L Knutson, M HoenigJournal of Cellular Biochemistry|September 15, 1996
Arachidonic acid-induced down-regulation of protein kinase C delta in beta-cellsK L Knutson, M HoenigBiochemical Medicine and Metabolic Biology|October 1, 1994
Effect of protein kinase C on the plasma membrane calcium pump in purified beta cellsM Hoenig, K L KnutsonPageof 6